Next generation prostate cancer therapy. Shows you how fast the technology is moving. It will be rewarded by the market in my opinion. The only negative I can see is that is tlx 591 going to be obsolete in 3 to 4 years. I think it is the best in class in stage 3 trials but might have a short shelf like. But that is the nature of the beast. The company is at the cutting edge of best in market and I like that as an investor. Anyone else see it this way ?
Next generation prostate cancer therapy. Shows you how fast the...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.46 |
Change
0.000(0.00%) |
Mkt cap ! $5.499B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5282 | $17.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.29 | 921 | 1 |
View Market Depth
| Last trade - 16.32pm 13/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |
Day chart unavailable